Therapy study with a diclofenac/orphenadrin infusion in patients with inflammatory osteoarthritis;DICLOFENAC/ORPHENADRIN-INFUSIONSTHERAPIE BEI PATIENTEN MIT AKTIVIERTEN ARTHROSEN

Wiener Medizinische Wochenschrift

Volumn 148, Issue 7, 1998, Pages 179-182

  Uitz, Elisabeth ^a   Aglas, F ^a   Wurm, Annelies ^b   Rainer, F ^b  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b Fresenius Kabi   (Austria)

Author keywords

Diclofenac; Infusion therapy; Orphenadrin; Osteoarthritis and inflammation; Osteoarthritis and pain

Indexed keywords

DICLOFENAC; ORPHENADRINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KNEE; MALE; MUSCULOSKELETAL SYSTEM INFLAMMATION; OSTEOARTHRITIS; VERTIGO; VISUAL ACUITY; VISUAL DEPRIVATION; VISUAL IMPAIRMENT; XEROSTOMIA;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KNEE JOINT; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; ORPHENADRINE; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031866223     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Abramson SB, Weissmann G: The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1989;32:1-9.
2. Bennet WM, DeBroe ME: Analgesic nephropathy: A preventable renal disease. N Engl J Med 1989;320:1269-1271.
3. Benson GD: Hepatotoxicity following the therapeutic use of antipyretic analgesics. Am J Med 1983;75:85-93.
4. Berger M, Gerstenbrand F, Musil HE: Infusionstherapie akuter vertebragener Schmerzsyndrome. Wien Med Wschr 1987;137:310-314.
5. Blackshear JL, Napier JS, Davidman M, Stillman MT: Renal complications of nonsteroidal antiinflammatory drugs: Identification and monitoring of those at risk. Sem Arthritis Rheum 1985;14:163-175.
6. Brodgen RN, Heel RC, Pakes GE, Speight TM, Avery GS: Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 1980;20: 24-48.
7. Carrabba M, Colombo B, Giovanni E, Cenacchi T: Ultra-structural approach to the understanding of osteoarthritis. Rheumatology 1982; 7:53-63.
8. Heinzel S: Muskarin-Rezeptoren. Med Monatsschr Pharm 1988; 11:359-360.
9. Hoivik HO, Moe N: Effect of a combination of orphenadrine / paracetamol tablets ("Norgesic") on myalgia; a double-blind comparison with placebo In general practice. Curr Med Res Opin 1983;8:531-535.
10. Hunskaar S, Donnell D: Clinical and pharmacological review of the efficacy of orphenadrine and its combination with paracetamol in painful conditions. J Int Med Res 1991;19:71-87.
11. Huskisson EC: Measurement of pain. Lancet 1974;11:1127-1131.
12. Kellgren JH, Lawrence JS: Radiological assessment of osteoarthritis. Ann Rheum Dis 1957;16:494-501.
13. Ku EC, Lee W, Kothari HV, Kimble EF, Liauw L, Tjan J: The effect of diclofenac sodium on arachidonic acid metabolism. Semin Arthritis Rheum 1985;15:36-41.
14. Mitchell JA, Akarasereenont P, Thlemermann C, Flower RJ, Van JR: Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acacl Sci USA 1994;90:11693-11697.
15. Reibaldi A, Lograno MD, Avitabile T: Iris receptors of fresh human eyes. Ann Ophthalmol 1984;16:746-748.
16. Sanfilippo S, Imbesi RM, Sanfilippo S, Parvez SH, Parvez S: Basal and Serotonin or Forskolin stimulated sarcolemmal Adenylatzyklase activity in the skeletal musculature of the intact and ontogenetically Serotonin free male rat: Quantitative differences in enzymeactivity between perineal and other skeletal muscles. Biogenic Amines 1997;13:1-17.
17. Schlegel SI, Paulus HE: Nonsteroidal and analgesic therapy in the elderly. Clin Rheumat Dis 1986;12:245-273.
18. Small RE: Diclofenac sodium. Clin Pharm 1989;8:545-558.
19. Soil AH, Weinstein WM, Kurota J, McCarthy D: Nonsteroidal antiinflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307-319.
20. Stern RS, Bigby M: A expanded profile of cutaneus reactions to nonsteroidal antiinflammatory drugs. JAMA 1984;252:1433-1437.
21. Szczeklik A: Antipyretic analgesics and the allergic patient. Am J Med 1983;75:82-84.
22. The International Agranulocytosis and Aplastic Anemia Study: Risks of agranulocytosis and aplaslic anemia: A first report of their relation to drug use with special reference to analgesics. JAMA 1986;256:1749-1757.
23. Von der Mark K: Differentiation, modulation and dedifferentiation of chondrocytes. Rheumatology 1986;10:272-315.
24. Willet LR, Carson JL, Strom BL: Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs. Drug Safety 1994;10:170-181.